Rheumatology

Your Article Summary

See Latest Articles

Fibromyalgia: Milnacipran: A New Treatment Option for Fibromyalgia
Practical Pain Management, 06/26/09

Mease PJ - On January 14, 2009 the Food and Drug Administration approved the use of SavellaTM (milnacipran) for the treatment of fibromyalgia. This third approved drug offers health care providers yet another treatment option for their fibromyaliga patients. Dr. Philip Mease’s detailed article covers the scientific specifics of Savella’s efficacy in a fibromyalgia treatment regimen and offers the promise of a better quality of life for people living with this chronic pain condition.

Today in Chr Fatigue/Fibromyalgia...keeping you current

Receive free subspecialty "5-minute updates" via email

What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of Duloxetine
Journal of Rheumatology, 10/16/09

Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome
Cochrane Reviews, 10/12/09

Fibromyalgia and Myofascial Pain Syndrome - A Dilemma
Indian Journal of Anaesthesia, 10/22/09

See All of Chr Fatigue/Fibromyalgia

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09

See All of Clinical Pharmacology